| CEO Name | Richard A. Gonzalez |
| Nationality | United States |
| Net Worth Estimation | $80 million |
Richard A. Gonzalez, CEO of AbbVie Inc., has an estimated net worth of around $80 million, largely accumulated through his executive compensation, performance-based stock awards, and long-term investments in AbbVie shares. His wealth reflects both his tenure since leading AbbVie's 2013 spinoff and the company's strong financial growth in the biopharmaceutical sector.
Richard A. Gonzalez, CEO of AbbVie Inc., has an estimated net worth of $80,000,000, which is 88.9% of the maximum estimated CEO net worth ($90,000,000) and 800% of the minimum ($10,000,000) for the healthcare category. His net worth positions him near the top tier among healthcare CEOs.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Richard A. Gonzalez Performance in AbbVie Inc.
Richard A. Gonzalez, CEO of AbbVie Inc., demonstrates strategic leadership by driving innovation and fostering collaborative decision-making to enhance company growth. His performance is marked by significant operational efficiency, robust R&D investments, and successful expansion in the pharmaceutical market. Under his leadership, AbbVie has achieved substantial revenue growth and strengthened its global presence, significantly impacting the company's industry position and shareholder value.
Latest News
AbbVie Reports Third-Quarter 2025 Financial Results: Major Investments and New Campaigns Announced
AbbVie reported a diluted EPS of $0.10 (GAAP), down 88.6%, but raised full-year adjusted guidance to $10.61-$10.65, citing strong strategic investments, including a $195 million API facility in North Chicago and new marketing initiatives for Botox Cosmetic and Juvederm. CEO Robert A. Michael, who also became chairman in July 2025, highlighted the company's diversified growth and commitment to innovative manufacturing expansions despite challenges like the Humira patent cliff.
Source: http://www.prnewswire.com/news-releases/abbvie-reports-third-quarter-2025-financial-results-302600511.html